Ara-A en es it fr

Ara-A Brand names, Ara-A Analogs

Ara-A Brand Names Mixture

  • No information avaliable

Ara-A Chemical_Formula


Ara-A RX_link

Ara-A fda sheet

Ara-A msds (material safety sheet)

Ara-A Synthesis Reference

No information avaliable

Ara-A Molecular Weight

285.257 g/mol

Ara-A Melting Point

No information avaliable

Ara-A H2O Solubility

No information avaliable

Ara-A State


Ara-A LogP


Ara-A Dosage Forms

No information avaliable

Ara-A Indication

For treatment of chickenpox - varicella, herpes zoster and herpes simplex

Ara-A Pharmacology

Vidarabine is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against herpes simplex virus types 1 (HSV-1), 2 (HSV-2), and varicella-zoster virus (VZV). The inhibitory activity of Vidarabine is highly selective due to its affinity for the enzyme thymidine kinase (TK) encoded by HSV and VZV. This viral enzyme converts Vidarabine into Vidarabine monophosphate, a nucleotide analogue. The monophosphate is further converted into diphosphate by cellular guanylate kinase and into triphosphate by a number of cellular enzymes. in vitro, Vidarabine triphosphate stops replication of herpes viral DNA. When used as a substrate for viral DNA polymerase, Vidarabine triphosphate competitively inhibits dATP leading to the formation of 'faulty' DNA. This is where Vidarabine triphosphate is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand.

Ara-A Absorption

No information avaliable

Ara-A side effects and Toxicity

No information avaliable

Ara-A Patient Information

No information avaliable

Ara-A Organisms Affected

Human Herpes Viruses